Condensed Consolidated Statements of Operations - Unaudited - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses
Research and development		$ 26,364	$ 11,558	$ 51,981	$ 40,048
General and administrative		13,455	9,180	28,714	47,152
Total operating expenses		39,819	20,738	80,695	87,200
Operating loss		(39,819)	(20,738)	(80,695)	(87,200)
Interest income		5,965	0	11,262	0
Interest expense		(4)	(170)	(7)	(184)
Net loss before income taxes		(33,858)	(20,908)	(69,440)	(87,384)
Income tax expense		965	1,223	2,292	2,233
Net loss before noncontrolling interest		(34,823)	(22,131)	(71,732)	(89,617)
Net loss attributable to noncontrolling interest		(25,705)	0	(52,949)	0
Net loss available to Class A ordinary shareholders		(9,118)		(18,783)
Common Class A [Member]
Operating expenses
Net loss available to Class A ordinary shareholders		$ (9,118)	$ (22,131)	$ (18,783)	$ (89,617)
Weighted Average Number of Shares Outstanding, Basic	[1]	64,562,209		64,551,281
Weighted Average Number Of Shares Outstanding, Diluted	[1]	64,562,209		64,551,281
Net loss per share attributable to Class A ordinary shares, Basic	[1]	$ (0.14)		$ (0.29)
Net loss per share attributable to Class A ordinary shares, Diluted	[1]	$ (0.14)		$ (0.29)

[1] (1) The Company analyzed the calculation of net loss per share for periods prior to the Business Combination, as defined in Note 1, on July 11, 2022 and determined that it resulted in values that would not be meaningful to the users of the consolidated financial statements, as the capital structure completely changed as a result of the Business Combination. Therefore, net loss per share information has not been presented for periods prior to the Business Combination. For more information refer to Note 8.